I agree that this site is using cookies. You can find further informations here.
X
Saussele, Susanne
81  results:
Articles (Online) X
Search for persons X
?
1

Treatment-free remission after a second TKI discontinuation..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia.  38 (2024)  4 - p. 781-787 , 2024
Link: https://doi.org/10.1038/..
 
?
2

Health-related quality of life and symptoms of chronic myel..:

Efficace, Fabio ; Mahon, Francois-Xavier ; Richter, Johan...
Leukemia.  , 2024
Link: https://doi.org/10.1038/..
 
?
3

Prediction of sustained remission after tyrosine kinase inh..:

Kockerols, Camille ; Valk, Peter J. M. ; Janssen, Jeroen J. W. M....
European Journal of Haematology.  , 2024
Link: https://doi.org/10.1111/..
 
?
4

Correction: Treatment-free remission after a second TKI dis..:

Flygt, Hjalmar ; Söderlund, Stina ; Richter, Johan...
Leukemia.  38 (2024)  4 - p. 925-925 , 2024
Link: https://doi.org/10.1038/..
 
?
5

Treatment of agitation in terminally ill patients with intr..:

Hirschinger, Hanna ; Jaeger, Evelyn ; Nittka, Stefanie...
BMC Palliative Care.  23 (2024)  1 - p. , 2024
Link: https://doi.org/10.1186/..
 
?
6

How to interpret the EURO-SKI study and its treatment-free ..:

Pfirrmann, Markus ; Saussele, Susanne ; Mahon, François-Xavier.
Leukemia.  38 (2024)  2 - p. 460-462 , 2024
Link: https://doi.org/10.1038/..
 
?
7

Management and outcome of patients with chronic myeloid leu..:

Brioli, Annamaria ; Lomaia, Elza ; Fabisch, Christian...
Leukemia.  38 (2024)  5 - p. 1072-1080 , 2024
Link: https://doi.org/10.1038/..
 
?
8

S159: HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH CHRON..:

Efficace, Fabio ; Mahon, Francois-Xavier ; Richter, Johan...
HemaSphere.  7 (2023)  S3 - p. e0972454 , 2023
Link: https://doi.org/10.1097/..
 
?
9

S157: NILOTINIB VS. NILOTINIB + PEG-INTERFERON ΑLPHA INDUCT..:

Hochhaus, Andreas ; Burchert, Andreas ; Saußele, Susanne...
HemaSphere.  7 (2023)  S3 - p. e4695659 , 2023
Link: https://doi.org/10.1097/..
 
?
10

S155: PROGNOSTIC FACTORS FOR 3-YEAR MAJOR MOLECULAR RESPONS..:

Pfirrmann, Markus ; Mahon, Francois-Xavier ; Dulucq, Stéphanie...
HemaSphere.  7 (2023)  S3 - p. e230884b , 2023
Link: https://doi.org/10.1097/..
 
?
11

Step-in dosing of bosutinib in pts with chronic phase chron..:

Isfort, Susanne ; Manz, Kirsi ; Teichmann, Lino L....
Annals of Hematology.  102 (2023)  10 - p. 2741-2752 , 2023
Link: https://doi.org/10.1007/..
 
?
12

P667: RISK OF PROGRESSION IN CHRONIC PHASE-CHRONIC MYELOID ..:

Paolo Maria Zambrotta, Giovanni ; Assouline, Sarit ; Nicolini, Franck E....
HemaSphere.  7 (2023)  S3 - p. e68411a2 , 2023
Link: https://doi.org/10.1097/..
 
?
13

Asciminib vs bosutinib in chronic-phase chronic myeloid leu..:

Hochhaus, Andreas ; Réa, Delphine ; Boquimpani, Carla...
Leukemia.  37 (2023)  3 - p. 617-626 , 2023
Link: https://doi.org/10.1038/..
 
?
14

Treatment‐free remission after dasatinib in patients with c..:

Shah, Neil P. ; García‐Gutiérrez, Valentín ; Jiménez‐Velasco, Antonio...
British Journal of Haematology.  202 (2023)  5 - p. 942-952 , 2023
Link: https://doi.org/10.1111/..
 
?
15

Gene Expression Pattern of ESPL1, PTTG1 and PTTG1IP Can Pot..:

Christiani, Eva ; Naumann, Nicole ; Weiss, Christel...
Cancers.  15 (2023)  9 - p. 2652 , 2023
Link: https://doi.org/10.3390/..
 
1-15